Literature DB >> 7625530

How many stool examinations are necessary to detect pathogenic intestinal protozoa?

R A Hiatt1, E K Markell, E Ng.   

Abstract

Recent reports have suggested that examination of one stool specimen is sufficient to detect protozoa in symptomatic patients. To verify this hypothesis, we examined specimens submitted to the regional laboratory of a large, prepaid health plan that provides primary care to a membership representative of the general population in northern California. We examined the number and results of stool specimen examinations in the two-month period before detection of Entamoeba histolytica in 125 infected persons, of Giardia lamblia in 154 infected persons, and of Dientamoeba fragilis in 60 persons infected with this parasite. About 13% of the entire group had a single stool specimen examined, 19% had two examined, 65% had three examined, and 6% had more than three examined. Most infections were detected in the first specimen or specimens submitted, but many were not detected until later examination. Thirteen patients with E. histolytica (10.4%) required 4-9 examinations. The sensitivity of one examination was compared with that of three examinations; with the additional examinations, the yield increased 22.7% (95% confidence interval [CI] = 11.8-33.5%) for E. histolytica, 11.3% (95% CI = 6.9-81.8%) for G. lamblia, and 31.1% (95% CI = 17.7-54.4%) for D. fragilis. Our results suggest that a single stool specimen examination will miss many pathogenic protozoan infections in symptomatic persons.

Entities:  

Mesh:

Year:  1995        PMID: 7625530

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  30 in total

1.  Triple Faeces Test: an effective tool for detection of intestinal parasites in routine clinical practice.

Authors:  T van Gool; R Weijts; E Lommerse; T G Mank
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-08       Impact factor: 3.267

Review 2.  Infections by Intestinal Coccidia and Giardia duodenalis.

Authors:  Vitaliano A Cama; Blaine A Mathison
Journal:  Clin Lab Med       Date:  2015-04-04       Impact factor: 1.935

Review 3.  Cryptosporidiosis in persons with HIV infection.

Authors:  B Ramratnam; T P Flanigan
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

4.  A review of the clinical presentation of dientamoebiasis.

Authors:  Damien Stark; Joel Barratt; Tamalee Roberts; Deborah Marriott; John Harkness; John Ellis
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

5.  Care-seeking behaviour and diagnostic processes for symptomatic giardiasis in children attending an academic paediatric hospital.

Authors:  Angel A Escobedo; Pedro Almirall; Ivonne Ávila; Yohana Salazar; Maydel Alfonso
Journal:  Pathog Glob Health       Date:  2014-09-24       Impact factor: 2.894

Review 6.  Laboratory Diagnosis of Parasites from the Gastrointestinal Tract.

Authors:  Lynne S Garcia; Michael Arrowood; Evelyne Kokoskin; Graeme P Paltridge; Dylan R Pillai; Gary W Procop; Norbert Ryan; Robyn Y Shimizu; Govinda Visvesvara
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

7.  Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents.

Authors:  D E Said; L M Elsamad; Y M Gohar
Journal:  Parasitol Res       Date:  2012-03-06       Impact factor: 2.289

Review 8.  Drugs for treating giardiasis.

Authors:  Carlos E Granados; Ludovic Reveiz; Luis G Uribe; Claudia P Criollo
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 9.  Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis.

Authors:  Eugene H Johnson; Jeffrey J Windsor; C Graham Clark
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 10.  Detection of intestinal protozoa in the clinical laboratory.

Authors:  Ian H McHardy; Max Wu; Robyn Shimizu-Cohen; Marc Roger Couturier; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.